Pfizer’s COVID-19 Shot Linked to Serious Damage to Eyes
A new peer-reviewed study out of Turkey has found that the Pfizer/BioNTech mRNA COVID-19 biologic (Comirnaty) may cause significant and measurable changes to eye health that, for some individuals, could contribute to long-term or even permanent vision complications. The study, published in Ophthalmic Epidemiology on July 14, 2025 tracked 64 patients over a 2.5-month period, […]
ACIP Majority Ignores Risks and Recommends Infants Get Merck’s RSV Monoclonal Antibody
On June 25, 2025, the majority of members of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ignored risk warnings and voted for a recommendation that infants be given Merck & Co.’s monoclonal antibody, clesrovimab, marketed as Enflonsia. The committee advised using Enflonsia to prevent Respiratory Syncytial Virus […]
Push for National Bird Flu Vaccine Program as USDA Points to Falling Egg Prices After Gains in Biosecurity Containment
Publicity about avian influenza (H5N1) infecting chickens, turkeys and cows in the United States1 and globally has been widespread for several years as fears about the possibility of bird flu epidemics among humans have led to calls for acceleration of development and use of animal and human bird flu vaccines.2 3 4 5 In February […]
Doomsday Chorus Targeting Kennedy Gets Louder
In a show of protest against budget and staffing cuts at the U.S. Centers for Disease Control and Prevention (CDC), former employees of the agency, scientists, and community activists organized a “die-in” demonstration outside the CDC’s Roybal Road campus in Atlanta, Georgia. On May 2, 2025, the Trump administration proposed a budget to Congress for […]
Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
A novel class of therapies that are labeled vaccines—known as ‘inverse vaccines’—are designed to treat autoimmune disorders and could be made available in just a few years. In January, Swiss biotech company Anokion—which focuses on improving treatments and health outcomes for individuals suffering with autoimmune disorders—announced promising early human trials of inverse “vaccines” targeting celiac […]
FDA Approves Yeztugo as Injectable Product to Prevent HIV in Adults and Adolescents
Last week, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir), the company’s injectable HIV-1 capsid inhibitor, for use as pre-exposure prophylaxis (PrEP). Yeztugo is not labeled a “vaccine” but is a pharmaceutical product intended to reduce the risk of acquiring human immunodeficiency virus (HIV) via sexual activity […]